Clinical Supply Planning Articles

1. When Clinical Supply Becomes A Clinical Decision 8/21/2026

   When clinical supply reveals a constraint, someone must decide what it means for patients and data. Strong governance turns those signals into accountable action.

2. How To Build Clinical Supply Into Drug Development From The Start 8/21/2026

   Clinical supply can do more than execute development decisions. Bringing it in early can expose product, process, packaging, and patient-access risks while they can still be changed.

3. When IRT Configuration Decisions Disrupt Clinical Supply 8/17/2026

   IRT decisions can make or break clinical supply. Craig Mooney explains how configuration, enrollment, inventory, and human oversight shape trial execution.

4. Fixing The Data Problem Before AI Can Help Clinical Trial Supply 8/14/2026

   AI cannot fix clinical trial supply forecasting when the underlying data is fragmented. Structuring enrollment, inventory, and label data comes first.

5. The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries 8/13/2026

   A shipment can arrive on time yet remain invisible to the systems that drive resupply. Discover how hidden data dependencies can create inventory problems where none exist.

6. When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line 8/11/2026

   Clinical supply plans can look perfect on paper but fail at the site. A Moorfields surgeon explains how supply delays, packaging, and workflow gaps affect trials and patients.

7. Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next 8/10/2026

   Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.

8. How AI Can Improve Clinical Supply Chain Visibility 8/5/2026

   AI can help clinical supply teams identify risks earlier, improve forecasting, and make faster, more informed decisions before disruptions affect trial continuity.

9. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

   Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.

10. Study Start-Up Is Where Clinical Supply Risk Is Actually Decided 8/3/2026

    Clinical supply risk begins long before the first shipment. Learn how study start-up decisions shape forecasting, inventory, manufacturing, and trial execution.